Market data

Select a section

Avacta Group

(AVCT)
Sector: Pharmaceuticals & Biotechnology
64.50p
0.00p 0.00
Last updated: 16:57:05

Company News Headlines

Date Time Headline Source
16/09/2024 07:00 Avacta Reported Updated Phase 1 Data of AVA6000 RNS
12/09/2024 07:00 Notice of Results RNS
09/09/2024 07:00 Avacta to present clinical data at ESMO Congress RNS
02/09/2024 15:53 Director/PDMR Shareholdings and TVR RNS
18/07/2024 07:00 Convertible Bond Payment RNS
26/06/2024 14:46 Result of AGM RNS
26/06/2024 07:00 AGM Business Update RNS
20/06/2024 07:00 Shaun Chilton appointed Non-Executive Chairman RNS
11/06/2024 07:00 Appointment of Nominated Adviser and Sole Broker RNS
31/05/2024 07:00 Posting of Annual Report and Notice of AGM RNS
23/05/2024 07:00 Successful Completion of First Cohort RNS
30/04/2024 07:01 Full Year Results RNS
30/04/2024 07:00 Board Change RNS
26/04/2024 09:51 Block listing Interim Return REPLACEMENT RNS
26/04/2024 07:00 Block Listing Six Monthly Return RNS
23/04/2024 09:43 Block Listing Application to AIM RNS
23/04/2024 07:00 Notice of Results RNS
22/04/2024 12:14 Issue of Equity and Total Voting Rights RNS
09/04/2024 17:00 Avacta Reports Data at the AACR Annual Meeting RNS
08/04/2024 07:00 AVA6000 Abstract Release by AACR RNS
21/03/2024 07:00 Update on AVA6000 Phase 1a Clinical Trial Progress RNS
18/03/2024 13:26 Result of General Meeting RNS
06/03/2024 07:00 Avacta Announces AVA6000 Poster at AACR RNS
05/03/2024 07:00 Result of REX Retail Offer RNS
29/02/2024 07:00 Result of Placing RNS
28/02/2024 16:42 Proposed REX Retail Offer RNS
28/02/2024 16:41 Proposed Fundraise to progress Therapeutics RNS
16/02/2024 07:00 Share Incentive Plan/Issue of Equity RNS
22/01/2024 10:51 Issue of Equity and Total Voting Rights RNS
19/01/2024 07:00 Appointment of Christina Coughlin RNS
19/12/2023 07:00 Appointment of Chief Business Officer RNS
13/12/2023 07:00 ALS-6000-101 Phase 1a Study Data RNS
04/12/2023 07:00 Shareholder update to review AVA6000 Phase 1a data RNS
27/10/2023 07:00 Block Listing Six Monthly Return RNS
23/10/2023 13:30 Issue of Equity and Total Voting Rights RNS
18/10/2023 13:00 Block Listing Application to AIM RNS
05/10/2023 07:00 Avacta to present at AACR-NCI-EORTC conference RNS
28/09/2023 07:00 Interim Results for the Period Ending 30 June 2023 RNS
20/09/2023 14:00 Issue of Equity and Total Voting Rights RNS
20/09/2023 07:01 Peel Hunt Appointed as Joint Broker RNS
20/09/2023 07:00 Appointment Dr.Christina Coughlin as a consultant RNS
19/09/2023 07:00 Successful Completion of Sixth Dose Escalation RNS
06/09/2023 07:00 Notice of Results RNS
21/07/2023 15:00 Issue of Equity and Total Voting Rights RNS
28/06/2023 11:00 Result of Annual General Meeting RNS
28/06/2023 07:00 Annual General Meeting and Shareholder Event RNS
21/06/2023 07:00 Completion of Fifth Dose Escalation in AVA6000 RNS
19/06/2023 07:01 Director Appointment RNS
19/06/2023 07:00 Statement regarding market speculation RNS
08/06/2023 07:00 AGM and Shareholder Event Detailed Agenda RNS

Market data

Select a section